Viva Biotech's Portfolio Companies Showcase Promising Advances in Biotechnology Viva Biotech's portfolio companies, including TechnoDerma and VivaVision, have shared exciting updates, demonstrating significant progress in clinical trials and therapies aimed at various health conditions.

Viva Biotech's Portfolio Companies Showcase Promising Advances in Biotechnology #VivaVision #Viva_Biotech #Technoderma

Positive Results from Technoderma's Phase 2a Trial of TDM-180935 for Atopic Dermatitis Technoderma Medicines announces successful Phase 2a trial results for TDM-180935 ointment in treating Atopic Dermatitis, showcasing strong efficacy and safety.

Positive Results from Technoderma's Phase 2a Trial of TDM-180935 for Atopic Dermatitis #China #Chengdu #Atopic_Dermatitis #Technoderma #TDM-180935